ArticleThe oncologist2025

Retrospective analysis to validate the CTS5 in patients from El Álamo IV registry and GEICAM adjuvant studies.

Sara Lopez-Tarruella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.